9 METERS BIOPHARMA INC's ticker is NMTR and the CUSIP is 654405109. A total of 89 filers reported holding 9 METERS BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $497,000 | -17.6% | 2,312,696 | 0.0% | 0.00% | – |
Q2 2022 | $603,000 | -73.6% | 2,312,696 | -39.2% | 0.00% | – |
Q1 2022 | $2,280,000 | -39.7% | 3,805,794 | -1.5% | 0.00% | – |
Q4 2021 | $3,782,000 | -19.7% | 3,864,762 | +6.6% | 0.00% | -100.0% |
Q3 2021 | $4,711,000 | +27.0% | 3,624,058 | +7.4% | 0.00% | 0.0% |
Q2 2021 | $3,710,000 | +142.3% | 3,373,509 | +157.7% | 0.00% | – |
Q1 2021 | $1,531,000 | +121.6% | 1,309,144 | +62.7% | 0.00% | – |
Q4 2020 | $691,000 | +128.1% | 804,475 | +115.8% | 0.00% | – |
Q3 2020 | $303,000 | +293.5% | 372,703 | +173.8% | 0.00% | – |
Q2 2020 | $77,000 | – | 136,146 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 3,250,000 | $1,948,000 | 0.42% |
ODonnell Financial Services, LLC | 854,375 | $512,000 | 0.23% |
Orbimed Advisors | 10,275,887 | $6,158,000 | 0.10% |
GSA CAPITAL PARTNERS LLP | 419,858 | $252,000 | 0.03% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 15,000,000 | $8,990,000 | 0.02% |
Prentice Wealth Management LLC | 39,525 | $23,000 | 0.01% |
Ascent Wealth Partners, LLC | 85,224 | $51,000 | 0.01% |
RWA WEALTH PARTNERS, LLC | 230,888 | $138,000 | 0.01% |
Sterling Investment Counsel, LLC | 17,533 | $11,000 | 0.01% |
Valeo Financial Advisors, LLC | 198,148 | $119,000 | 0.01% |